Showing results (1871-1880 of 2,454) with videos related to

Sort By:
Pageof 246
BMC Urology|April 13, 2022
Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective studyAkinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura, et al.
BMC Urology|October 13, 2021
Presepsin as a predictor of septic shock in patients with urinary tract infectionYoshitaka Sekine, Kazuhiko Kotani, Daisuke Oka, et al.
BMC Urology|October 20, 2021
Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trialNikan Zerafatjou, Mohammadali Amirzargar, Mahdi Biglarkhani, et al.
BMC Urology|January 30, 2022
The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methodsRia Winkelmann, Katrin Bankov, Jens von der Grün, et al.
BMC Urology|March 12, 2022
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and JapanAndrea Leith, Amanda Ribbands, Jeri Kim, et al.
BMC Urology|March 8, 2022
One-stage tubeless percutaneous nephrolithotomy for asymptomatic calculous pyonephrosisShijie Guo, Xicai Zhang, Fengyue Li, et al.
BMC Urology|July 12, 2019
Testicular cancer in Geneva, Switzerland, 1970-2012: incidence trends, survival and risk of second cancerRobin Schaffar, Samaksha Pant, Christine Bouchardy, et al.
BMC Urology|March 30, 2022
Ureteral reimplantation during augmentation cystoplasty is not needed for vesicoureteral reflux in patients with neurogenic bladder: a long-term retrospective studyHiroki Chiba, Takeya Kitta, Madoka Higuchi, et al.
BMC Urology|March 30, 2022
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trialsJonathan A Gelfond, Brian Hernandez, Martin Goros, et al.
BMC Urology|January 10, 2023
A high high-density lipoprotein level is associated with Gleason score upgrade in Chinese patients diagnosed with high-grade prostate carcinomaJingcheng Lyu, Lu Li, Tianyu Jiang, et al.
Pageof 246